Antony A. Riley - 31 Jul 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Chief Financial Officer
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Issuer symbol
FBRX
Transactions as of
31 Jul 2023
Net transactions value
+$149,999
Form type
4
Filing time
02 Aug 2023, 17:57:13 UTC
Previous filing
05 Jul 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Award $149,999 +148,514 +525% $1.01 176,776 31 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,500 shares of Common Stock acquired July 3, 2023 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan.